Description: Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
Home Page: www.epitomeemedical.com
Tarshish Industrial Park Street 19
Caesarea,
3088900
Israel
Phone:
Officers
| Name | Title |
|---|---|
| Dr. Shimon Eckhouse Ph.D. | Co-Founder & Chairman |
| Dr. Dan Hashimshony Ph.D. | Chief Exec. Officer |
| Ms. Maya Gabrieli | VP of Fin. |
| Mr. Gal Aharonowitz | Chief Operating Officer |
| Ms. Safi Landskroner | VP of Bus. Devel. & Marketing |
| Dr. Ruthie Amir M.D. | Chief Medical & Regulatory Officer |
Exchange: TA
Country: IL
Currency: Israeli Agora (ILA)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.4821 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |